Drug Approval | March 07, 2024
Sakar's oncology unit receives EU GMP approval
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
ANVISA issues CGMP to Concord Biotech’s Unit I
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The board gave in-principle approval for expansion of company's footprint in Lucknow
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
The CDCCs are strategically positioned in regions identified as high-impact areas
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
_256_384.png){kind=logo}
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Subscribe To Our Newsletter & Stay Updated
